ObsEva (NASDAQ:OBSV) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research report report published on Monday morning. The brokerage issued a hold rating on the stock.

ObsEva Stock Performance

OBSV stock opened at $0.01 on Monday. The firm has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.04. ObsEva has a 52 week low of $0.08 and a 52 week high of $2.14. The stock has a market cap of $389,855.00, a P/E ratio of -0.01 and a beta of 0.68.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.